Kumar Neil sold BBIO
August 19, 2026 · Form 4 insider transaction
Kumar Neil sold 100 shares of BridgeBio Pharma, Inc. at $85.65 per share, a transaction worth $8.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$85.65
Total value
$8.6K
InsiderKumar Neil
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 19, 2026
Filing dateAugust 20, 2026
Shares owned after505,686
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 13, 2026.; The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.